Production (Stage)
Zentalis Pharmaceuticals, Inc.
ZNTL
$1.20
-$0.04-3.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -32.01% | -23.16% | -24.27% | -22.89% | 24.58% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -29.64% | -27.66% | -22.44% | 20.91% | -16.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -31.94% | -22.28% | -24.23% | -22.04% | 22.81% |
|
|
|||||
| Total Current Assets | -31.94% | -22.28% | -24.23% | -22.04% | 22.81% |
| Net Property, Plant & Equipment | -12.95% | -10.80% | -9.77% | -10.23% | -8.91% |
| Long-term Investments | -- | -- | 0.00% | 0.00% | 0.00% |
| Goodwill | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -37.40% | -25.84% | -26.05% | -9.75% | -21.37% |
| Total Assets | -31.11% | -22.00% | -23.06% | -20.88% | 13.92% |
|
|
|||||
| Total Accounts Payable | -26.02% | -50.17% | -42.50% | 66.11% | -18.07% |
| Total Accrued Expenses | -7.29% | 69.78% | 3.52% | 16.16% | -0.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 28.11% | 17.12% | 15.84% | 16.02% | 21.90% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -9.80% | -23.99% | -6.86% | 28.85% | -2.77% |
|
|
|||||
| Total Current Liabilities | -9.80% | -23.99% | -6.86% | 28.85% | -2.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.30% | -8.28% | -6.49% | -6.15% | -4.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -56.88% | -52.30% | -39.05% | -54.17% | -49.22% |
| Total Liabilities | -10.20% | -18.50% | -7.21% | 11.14% | -4.79% |
|
|
|||||
| Common Stock & APIC | 4.58% | 5.09% | 3.81% | 4.14% | 27.82% |
| Retained Earnings | -25.52% | -18.66% | -21.66% | -25.21% | -33.19% |
| Treasury Stock & Other | -53.69% | -74.57% | 544.01% | 141.42% | 239.03% |
| Total Common Equity | -35.61% | -22.89% | -26.45% | -26.87% | 19.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.61% | -22.89% | -26.45% | -26.87% | 19.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.61% | -22.91% | -26.47% | -26.89% | 18.96% |
|
|
|||||